RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
#DISRUPTOR #CANCER $AAPL $TSLA $AMZN $NWBO #SPOOFING #CITADEL @InvestorTurf https://t.co/JlVwuMKxx9 https://t.co/ghJpl9W9tr NWBO Mine of DIAMONDS https://t.co/xZhhBFOtVZ https://t.co/uZK5NwD4fY https://t.co/EbUWf8VmFO UK MIA MAA $Prtnshp Combo TrialS UPLI
RT @flaskworks: @Siobhain_Mc @shitscaredmum @MHRAgovuk @NICEComms should approve and fully reimburse the life-saving vaccine DCVax from @No…
Phase 3 Data #DCVaxL $NWBO @UCLAHealthNews @UCLAHealth https://t.co/8hsMn0KvFC
@Siobhain_Mc @shitscaredmum @MHRAgovuk @NICEComms should approve and fully reimburse the life-saving vaccine DCVax from @NorthwestBio! https://t.co/UbQi4GcguH https://t.co/ZN5EWgWgZO $NWBO
@GREEK__G0D That's common practice in pre-revenue biotechnology firms. Most fail yet $NWBO has risen to the top. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/4wuqeo6jWO https://t.co/m0FMWDAnBB https://t.co/mVKZxkIgnc https://t.co/Z
RT @flaskworks: @Bioshitz @apwriter You must be talking about another company not $NWBO. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @flaskworks: @Bioshitz @apwriter You must be talking about another company not $NWBO. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn…
@Bioshitz @apwriter You must be talking about another company not $NWBO. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/4wuqeo6jWO https://t.co/m0FMWDAnBB https://t.co/mVKZxkIgnc https://t.co/ZN5EWgVJag https://t.co/I5FQwGLxsC
@MiglioriniDenis #dcvax #allsolidtumors #nwbo Your flawed paper was asking for DCVax evidence:- https://t.co/bCF9Twndz3 https://t.co/VJ1TAUPqCJ https://t.co/kBdZtE4H7L (Be sure to read all the supplements)
@Timothee_MD @MiglioriniDenis @DOncologie #dcvax #allsolidtumors #nwbo Your flawed paper was asking for DCVax-L evidence:- https://t.co/bCF9Twndz3 https://t.co/VJ1TAUPqCJ https://t.co/kBdZtE4H7L (Be sure to read all the supplements)
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @flaskworks: @HulkInvestments Cure for cancer? Check out $NWBO. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/4wuqeo6…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
https://t.co/M6qH2lrToM $nwbo @alphavestcap
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
RT @HenryMuney: Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JA…
Dr. Daniela Bota is one of the co-authors of the #DCVax-L Phase 3 trial @JAMAOnc publication, "The results, published in JAMA Oncology, are widely heralded." @UCIrvineHealth 1. https://t.co/6KwBzU7ffq 2. https://t.co/pfRDJT4azX $NWBO https://t.co/7P7SVRw
RT @flaskworks: @Siobhain_Mc In fact $NWBO's DCVax already has MHRA MIA license. Landmark PIII Trial Data published in @JAMAOnc. https://…
@Siobhain_Mc In fact $NWBO's DCVax already has MHRA MIA license. Landmark PIII Trial Data published in @JAMAOnc. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/4wuqeo6jWO https://t.co/m0FMWDAnBB https://t.co/mVKZxkIgnc https://t.co/wS
RT @flaskworks: @Persian1010 @Biohazard3737 @gamechangercap @BiotechTVHQ In my opinion $NWBO will bankrupt $NVCR. https://t.co/UbQi4GbIF9…
RT @flaskworks: @richtrades100 No value actually in $NVCR as $NWBO are putting them out of business in my opinion. $4B market cap loss to…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @flaskworks: @Persian1010 @Biohazard3737 @gamechangercap @BiotechTVHQ In my opinion $NWBO will bankrupt $NVCR. https://t.co/UbQi4GbIF9…
@bearcapital1 @babykailan74 You will own $NWBO shares by next year. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/4wuqeo6jWO https://t.co/m0FMWDAnBB https://t.co/mVKZxkIgnc https://t.co/ddZf8ja6SK
RT @flaskworks: @lipa0902 Notacure longs should buy $NWBO. It actually works. $NVCR management dump their stock all of the time. Can't…
RT @flaskworks: @richtrades100 No value actually in $NVCR as $NWBO are putting them out of business in my opinion. $4B market cap loss to…
RT @flaskworks: @Persian1010 Million dollars a year, in perpetuity, for basically no survival benefit. No thanks $NVCR scam artists! $NWB…
RT @flaskworks: @Persian1010 Million dollars a year, in perpetuity, for basically no survival benefit. No thanks $NVCR scam artists! $NWB…
RT @flaskworks: @richtrades100 No value actually in $NVCR as $NWBO are putting them out of business in my opinion. $4B market cap loss to…
RT @flaskworks: @Persian1010 Million dollars a year, in perpetuity, for basically no survival benefit. No thanks $NVCR scam artists! $NWB…
@Persian1010 @Biohazard3737 @gamechangercap @BiotechTVHQ In my opinion $NWBO will bankrupt $NVCR. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/4wuqeo6jWO https://t.co/m0FMWDAnBB https://t.co/mVKZxkIgnc
@richtrades100 No value actually in $NVCR as $NWBO are putting them out of business in my opinion. $4B market cap loss today means I am likely correct. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/4wuqeo6jWO https://t.co/m0FMWDAnBB
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @eastvillagetwt: Shorts can't stop $NWBO. They can play around the edges, pretend to know things they do not know or imply things that…
RT @flaskworks: @Persian1010 Million dollars a year, in perpetuity, for basically no survival benefit. No thanks $NVCR scam artists! $NWB…
RT @flaskworks: @Persian1010 Million dollars a year, in perpetuity, for basically no survival benefit. No thanks $NVCR scam artists! $NWB…
RT @flaskworks: @lipa0902 Notacure longs should buy $NWBO. It actually works. $NVCR management dump their stock all of the time. Can't…
RT @alphavestcap: https://t.co/DzZFTECCeF $nwbo $nvcr @alphavestcap
RT @flaskworks: @Persian1010 Million dollars a year, in perpetuity, for basically no survival benefit. No thanks $NVCR scam artists! $NWB…
RT @flaskworks: @lipa0902 Notacure longs should buy $NWBO. It actually works. $NVCR management dump their stock all of the time. Can't…
RT @flaskworks: @Persian1010 Million dollars a year, in perpetuity, for basically no survival benefit. No thanks $NVCR scam artists! $NWB…
@Persian1010 Million dollars a year, in perpetuity, for basically no survival benefit. No thanks $NVCR scam artists! $NWBO actually works! https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/4wuqeo6jWO https://t.co/m0FMWDAnBB https://t.co/
https://t.co/DzZFTECCeF $nwbo $nvcr @alphavestcap
@lipa0902 Notacure longs should buy $NWBO. It actually works. $NVCR management dump their stock all of the time. Can't trust them! https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/4wuqeo6jWO https://t.co/m0FMWDAnBB https://t.co/mVKZx
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: @CNBCPro What about $NWBO? C suite at #ASCO23 IET June 3rd 3PM CDT discussing the platform for all solid tumors. Landmark…
RT @flaskworks: @BursatilBiotech @bradloncar @JacobPlieth JAMA loves $NWBO's DCVax. https://t.co/UbQi4GcguH https://t.co/s8AGTeVhLV htt…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: @BursatilBiotech @bradloncar @JacobPlieth JAMA loves $NWBO's DCVax. https://t.co/UbQi4GcguH https://t.co/s8AGTeVhLV htt…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
RT @flaskworks: Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for…
Heard of DCVax #Immunotherapy by @NorthwestBio? Learn about $NWBO's Landmark Trial Data for Glioblastoma, future plans for all solid tumors, 3PM today at #ASCO23 IET! https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/m0FMWDAnBB https://t.c
@hiltzikm Actual Phase 3 results https://t.co/HWiEyOREPD
RT @flaskworks: @CNBCPro What about $NWBO? C suite at #ASCO23 IET June 3rd 3PM CDT discussing the platform for all solid tumors. Landmark…
RT @flaskworks: @JacobPlieth Are you going to interview $NWBO's Marnix Bosch at #ASCO2023 IET who will be discussing DCVax for all solid tu…
RT @flaskworks: @CNBCPro What about $NWBO? C suite at #ASCO23 IET June 3rd 3PM CDT discussing the platform for all solid tumors. Landmark…
RT @flaskworks: @SodApOpPIMPski 80K views, in a few months, for $NWBO's Landmark Trial Data contradict your erroneous claims. https://t.co…
RT @flaskworks: @CNBCPro What about $NWBO? C suite at #ASCO23 IET June 3rd 3PM CDT discussing the platform for all solid tumors. Landmark…
RT @flaskworks: @CNBCPro What about $NWBO? C suite at #ASCO23 IET June 3rd 3PM CDT discussing the platform for all solid tumors. Landmark…
RT @flaskworks: @CNBCPro What about $NWBO? C suite at #ASCO23 IET June 3rd 3PM CDT discussing the platform for all solid tumors. Landmark…
RT @flaskworks: @CNBCPro What about $NWBO? C suite at #ASCO23 IET June 3rd 3PM CDT discussing the platform for all solid tumors. Landmark…
RT @flaskworks: @SodApOpPIMPski 80K views, in a few months, for $NWBO's Landmark Trial Data contradict your erroneous claims. https://t.co…
RT @flaskworks: @CNBCPro What about $NWBO? C suite at #ASCO23 IET June 3rd 3PM CDT discussing the platform for all solid tumors. Landmark…
@SodApOpPIMPski 80K views, in a few months, for $NWBO's Landmark Trial Data contradict your erroneous claims. https://t.co/UbQi4GbIF9